Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

501

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

January 21, 2021

Study Completion Date

January 21, 2022

Conditions
Heart Arrest
Interventions
DRUG

Vasopressin, Arginine

20 IE of vasopressin per dose for a maximum of four doses (80 IU)

DRUG

Methylprednisolone

40 mg methylprednisolone once

DRUG

NaCl

Placebo

Trial Locations (10)

Unknown

Aalborg University Hospital, Aalborg

Aarhus University Hospital, Aarhus

Copenhagen University Hospital - Rigshospitalet, Copenhagen

Copenhagen University Hospital - Gentofte, Hellerup

Copenhagen University Hospital - Herlev, Herlev

Horsens Regional Hospital, Horsens

Zealand University Hospital - Køge, Køge

Odense University Hospital, Odense

Randers Regional Hospital, Randers

Viborg Regional Hospital, Viborg

All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Lars Wiuff Andersen

OTHER

NCT03640949 - Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest | Biotech Hunter | Biotech Hunter